Lymph
- Product NDC
- 43857-0482
- 11-digit product format
- 438570482
- Labeler code
- 43857
- Product ID
- 43857-0482_44179148-4a83-4799-a342-47f3adf40e2f
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Echinacea (Angustifolia), Phytolacca Decandra, Boldo, Pinus Sylvestris, Thyroidinum (Suis), Germanium Sesquioxide, Arnica Montana, Calcarea Iodata, Hamamelis Virginiana, Hepar Sulphuris Calcareum, Adenosinum Triphosphoricum Dinatrum, Ubidecarenonum, Naja Tripudians, Calcarea Phosphorica, Influenzinum, Natrum Sulphuricum, Pyrogenium, Sulphur, Carcinosin
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- BioActive Nutritional, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2018-05-30
- Marketing end
- 2023-07-18
- Substance
- ECHINACEA ANGUSTIFOLIA; PEUMUS BOLDUS LEAF; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; SUS SCROFA THYROID; GERMANIUM SESQUIOXIDE; ARNICA MONTANA; CALCIUM IODIDE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; CALCIUM SULFIDE; ADENOSINE TRIPHOSPHATE DISODIUM; UBIDECARENONE; NAJA NAJA VENOM; TRIBASIC CALCIUM PHOSPHATE; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (PROPIOLACTONE INACTIVATED); SODIUM SULFATE; RANCID BEEF; SULFUR; HUMAN BREAST TUMOR CELL
- Active strength
- 1 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43857-0482-1 | 43857048201 | 60 mL in 1 BOTTLE, DROPPER (43857-0482-1) | 60 ml | 2018-05-30 | 2023-07-18 | No | No | Current |